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Abstract
Background: To assess brachytherapy catheter positioning accuracy and to evaluate the effects of prolonged
irradiation time on the tolerance dose of normal liver parenchyma following single-fraction irradiation with
192 Ir.
Materials and methods: Fifty patients with 76 malignant liver tumors treated by computed tomography (CT)-
guided high-dose-rate brachytherapy (HDR-BT) were included in the study. The prescribed radiation dose was
delivered by 1 - 11 catheters with exposure times in the range of 844 - 4432 seconds. Magnetic resonance
imaging (MRI) datasets for assessing irradiation effects on normal liver tissue, edema, and hepatocyte dysfunction,
obtained 6 and 12 weeks after HDR-BT, were merged with 3D dosimetry data. The isodose of the treatment plan
covering the same volume as the irradiation effect was taken as a surrogate for the liver tissue tolerance dose.
Catheter positioning accuracy was assessed by calculating the shift between the 3D center coordinates of the
irradiation effect volume and the tolerance dose volume for 38 irradiation effects in 30 patients induced by
catheters implanted in nearly parallel arrangement. Effects of prolonged irradiation were assessed in areas where
the irradiation effect volume and tolerance dose volume did not overlap (mismatch areas) by using a catheter
contribution index. This index was calculated for 48 irradiation effects induced by at least two catheters in 44
patients.
Results: Positioning accuracy of the brachytherapy catheters was 5-6 mm. The orthogonal and axial shifts between
the center coordinates of the irradiation effect volume and the tolerance dose volume in relation to the direction
vector of catheter implantation were highly correlated and in first approximation identically in the T1-w and T2-w
MRI sequences (p = 0.003 and p < 0.001, respectively), as were the shifts between 6 and 12 weeks examinations (p
= 0.001 and p = 0.004, respectively). There was a significant shift of the irradiation effect towards the catheter entry
site compared with the planned dose distribution (p < 0.005). Prolonged treatment time increases the normal
tissue tolerance dose. Here, the catheter contribution indices indicated a lower tolerance dose of the liver
parenchyma in areas with prolonged irradiation (p < 0.005).
Conclusions: Positioning accuracy of brachytherapy catheters is sufficient for clinical practice. Reduced tolerance
dose in areas exposed to prolonged irradiation is contradictory to results published in the current literature. Effects
of prolonged dose administration on the liver tolerance dose for treatment times of up to 60 minutes per HDR-BT
session are not pronounced compared to effects of positioning accuracy of the brachytherapy catheters and are
therefore of minor importance in treatment planning.
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Single-fraction
192Ir high-dose-rate brachytherapy (HDR-
BT) of the liver is an ablation technique which has
shown promising results with respect to safety and
efficacy in the treatment of nonresectable primary and
secondary liver malignancies [1-3]. HDR-BT provides
steep dose gradients at the surface of the target volume
due to the low g-ray energy of
192Ir and use of a point
source, and thus can be used to treat several malignan-
cies in one session or recurrent malignancies sequentially
without seriously impairing the functional hepatic reserve
[4]. To prevent recurrence at the tumor margins, catheter
placement and dwell positions of the
192 Ir point source
have to be carefully planned [5]. The accuracy of dose
application is predominantly dependent on catheter posi-
tioning. Computed tomography (CT) was used to moni-
tor catheter implantation, and 3D CT datasets acquired
in breath-hold were used for treatment planning. For
irradiation patients were transferred from the CT unit to
the brachytherapy unit. Dislocation of catheters during
patient transfer might be a potential source of error with
respect to correct dose application at the target site.
Additionally, the liver is an elastic organ and could be
deformed between catheter implantation and irradiation.
The treatment of larger tumors with an
192Ir point
source requires the implantation of approximately 1
catheter for each 1 - 2 cm of tumor diameter. The con-
tributions of several catheters with numerous dwell
positions to the planned dose in a large part of the tar-
get volume lead to regional prolongation of irradiation.
Several authors describe an increased normal tissue dose
tolerance for prolonged radiation therapy or pulsed dose
rate (PDR) radiation therapy [6,7] even if the total irra-
diation time is less than one hour [8].
The present study aims at addressing two methodical
aspects of HDR-BT: First, to investigate the limits of
catheter positioning accuracy and its clinical importance.
Second, to investigate if effects of prolonged irradiation
times on the tolerance dose of normal liver parenchyma
are important for clinical practice and may have to be
taken into account in treatment planning.
2 Methods
Study population
In this study we retrospectively analyzed irradiation
effects on normal liver tissue in 50 consecutive patients
who underwent CT-guided single-fraction HDR-BT as
part of a clinical phase II study prospectively assessing
local tumor control. In 50 HDR-BT sessions a total of
76 solid primary or secondary liver tumors were treated
(1 - 4 malignant tumors per session). The study was
approved by the local ethics committee. Written
informed consent was obtained from all patients.
Interventional technique
The interventional technique has been described in
detail elsewhere [9]. In brief, a T2-weighted (T2-w)
respiratory-triggered ultrafast turbo spin echo (UTSE)
and a T1-weighted (T1-w) breath-hold gradient echo
(GRE) sequence with administration of the hepatocyte-
specific contrast agent gadobenate dimeglumine (Gd-
BOPTA (Multihance), Bracco, Princeton, NJ) were
acquired to delineate primary and secondary liver
lesions (see Follow-up section below). The brachyther-
apy catheters were positioned using CT guidance
(Somatom 4, Siemens, Erlangen, Germany), i.e., CT
scans were acquired continuously during the interven-
tional procedure with an image reconstruction rate of
12 per second to monitor actual catheter location. They
were placed in 6F angiographic sheaths (Radiofocus,
Terumo, Japan), which were implanted in Seldinger
technique within the tumors.T h ea n g i o g r a p h i cs h e a t h s
were sutured to the skin. After catheter positioning, a
spiral CT scan of the liver (matrix size, 512 × 512; slice
thickness, 5 mm; increment, 5 mm) enhanced by intra-
venous administration of iodine contrast medium (100
ml Ultravist 370; flow, 1 ml/s; start delay, 80s) was
acquired in breath-hold technique for treatment plan-
ning. Four catheters were implanted on average per
HDR-BT session (range, 1 - 11 catheters).
Treatment planning and irradiation
Treatment was planned using the BrachyVision software
package, version 7.1 (Varian Medical Systems, Palo Alto,
CA). The dwell positions and irradiation times were
optimized to ensure delivery of the prescribed dose to
the entire clinical target volume (CTV), see Figure 1.
The 24-channel HDR afterloading system (Gammamed
12i, Varian, Charlottesville, VA) employed a
192Ir source
(nominal source strength, 370GBq). A dose of 15, 20, or
25Gy was prescribed, which was planned to enclose the
lesion (clinical target volume). Compromises were
necessary if organs of risk such as the stomach, small
intestine, or a large bile duct were very close to the tar-
get. No upper limit was defined for the dose within the
tumor volume. To preserve liver function after irradia-
tion, one third of the liver parenchyma should receive a
dose of less than 5Gy. The effective irradiation time
needed to apply the target dose with all catheters was
corrected according to the actual
192 Ir source strength.
We usually limit the maximum irradiation time to 60
minutes to increase patient comfort. The catheters were
then sequentially connected to the afterloading system
according to the prescribed enumeration, and irradiation
was started at the most distant dwell position in each
catheter. All dwell positions within one catheter were
sequentially irradiated without any delay. An interval of
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catheter. Manual sequential connection of the catheters
was necessary because only a single adapter was avail-
able for connecting the catheters to the afterloader. The
exposure times were in the range of 844 - 4432 seconds.
Follow-up
A total of 161 MRI examinations were performed 6 ± 2
weeks and 12 ± 2 weeks after HDR-BT. The MRI proto-
col comprised the following sequences (Gyroscan NT
Intera, Philips, The Netherlands) [10]: T2-w respiratory-
triggered UTSE (echo time/repetition time (TE/TR), 90/
2100 ms; echo train length (ETL), 21; slice thickness, 8
mm, acquired in interleaved mode with no gap) with fat
suppression to assess the extent of interstitial edema
and T1-w breath-hold GRE (TE/TR 5/30 ms; flip
angle,30°; slice thickness, 8 mm, acquired in, interleaved
mode with no gap) 2 h after intravenous injection of 15
ml gadobenate dimeglumine (Gd-BOPTA (Multihance),
Bracco, Princeton, NJ). The hepatocyte-specific contrast
agent gadobenate dimeglumine allowed visualization of
the extent of hepatocyte dysfunction. The underlying
mechanism of intracellular uptake is a polyspecific
organic anionic transport [11-13].
Image registration
Merging of the 3D dosimetry data calculated by BrachyVi-
sion with the corresponding follow-up MRI scans was
accomplished using an independent image registration
implementation within the 3D visualization software
Amira 3.1 (Mercury Computer Systems, Berlin, Germany).
The image voxel-property-based registration method
allowed affine transformation (12 degrees of freedom: 3
r o t a t i o n s ,3t r a n s l a t i o n s ,3s c a l i n g s ,a n d3s h e a r s )b y
exploring the normalized mutual information (NMI) [14],
see Figure 2A. The liver including a 1-cm margin was seg-
mented in the treatment planning CT. The segmented
data served as reference for registration to optimize regis-
tration accuracy for the liver. Registration accuracy was
validated using intrahepatic vessel bifurcations as land-
marks. Three to four landmarks were set in the CT and
MRI image data of ten patients. Distances between the
landmarks in the coregistered images (CT vs. MRI) were
determined using the differences between the absolute
positions determined with Amira. A total of 120 coregis-
tered landmark combinations were evaluated.
Calculation of normal liver tissue tolerance dose
The borders of hyperintensity on T2-w images (intersti-
tial edema) and hypointensity on late Gd-BOPTA-
Figure 1 Geometry. The 3D visualization shows a CT slice with the
calculated dose in Gy overlayed. The dose is applied using two
catheters. The two catheters were visualized in 3D using surface
rendering of the catheters labeled in the CT scan.
A)
B)
5 Gy
10 Gy
15 Gy
20 Gy
Lesion
Figure 2 Image registration. A) T2-w image coregistered with the
planning CT. Note that only the liver was coregistered and
therefore good matching of the images was only achieved for the
liver. B) T2-w image showing segmented lesion and isodoses at 12-
week follow-up. A prononounced shift of the irradiation effect with
respect to the planned dose distribution as shown in this example
was typically not found.
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the irradiated liver tumors were outlined, see Figure 2B.
The volume of each irradiation effect was determined.
As the next step, we used this volume to calculate the
3D-isodose, which was confined to the liver and encom-
passed a corresponding volume (± 1%). The calculated
isodose was taken as a surrogate for the tolerance dose
of normal liver tissue assuming consistency between an
observed radiation effect and the dose applied [9]. The
volume encompassed by the isodose surface will be
referred to as tolerance dose volume in the following.
The mismatch areas between both volumes were investi-
gated in detail for the effect of prolonged irradiation
time, see Figure 3.
Measurement of lesion volume shift in relation to
planned volume
Potential inaccuracies of the treatment planning proce-
dure or catheter dislocation were analyzed by calculating
the shift between the center coordinates of the irradia-
tion effect volume and the tolerance dose volume using
t h ec o o r d i n a t es y s t e mo ft h ep l a n n i n gC T .O n l yt h o s e
brachytherapies were evaluated in which the catheters
were implanted unidirectionally, i.e., in parallel (n = 38).
The direction vector of an implanted catheter was cal-
culated from the coordinates of the catheter skin entry
site and the catheter tip in the treatment planning CT.
If more than one catheter was implanted, an average
coordinate from the coordinates of the entry sites and
of the catheter tips was calculated. The direction vector
of catheter implantation was converted into a unit vec-
tor   e with unit length 1 cm.
The shift vector   S describing the shift between the
irradiation effect volume and the tolerance dose volume
was calculated from the center coordinates of both
volumes. The scalar product of the unit vector and the
shift vector, Saxial =   e ·   S, was taken as a measure of the
shift between irradiation effect volume and tolerance
dose volume axial to the direction vector of catheter
implantation. It serves as a surrogate for catheter dislo-
cation within the catheter track. The vector product of
both vectors, Sortho = |  e ×   S|, provides a measure of the
orthogonal shift between the center coordinates of the
irradiation effect volume and the tolerance dose volume
in relation to the direction vector of catheter implanta-
tion. Since movement of the brachytherapy catheters
within the liver is limited to the catheter track the
orthogonal shift results mainly from methodical limita-
tions of image registration due to local liver deforma-
tion. The vector product thus serves as an additional
surrogate for registration inaccuracy.
An asymmetry coefficient of the scalar and vector pro-
duct was calculated to differentiate between a systematic
shift and registration inaccuracy:
ACS =
|Saxial|−Sortho
0.5(|Saxial| + Sortho)
(1)
A positive value of the asymmetry coefficient indicates
a shift predominantely parallel to the direction vector of
the implanted catheter, whereas a negative value indi-
cates a shift predominantly orthogonal to the direction
vector of the implanted catheter.
Evaluation of prolonged irradiation time
Irradiation took up to 4432 seconds (≈ 74 minutes)
using multiple catheters with numerous dwell positions
of the
192Ir source. Therefore, in areas with significant
dose contribution of several catheters, dose delivery
time was prolonged and may be characterized as pulsed
dose administration. The effects of regionally longer,
pulsed irradiation were investigated in areas where the
extent of hepatocyte dysfunction and edema was not
consistent with the applied dose. Only radiation effects
induced by at least 2 brachytherapy catheters were
assessed (n = 48).
We used a boolean tool implemented in Amira 3.1 to
identify nonoverlapping areas of the irradiation effect
volume and the corresponding tolerance dose isovolume
(confined to the liver). These areas will be referred to as
mismatch areas in the following. Mismatch areas where
edema or hepatocyte dysfunction occurred at doses
Lesion
16.2 Gy isodose surface
MA-
MA+
Figure 3 Mismatch areas. T2-w image showing segmented
irradiation effect and 16.2Gy isodose encompassing the
corresponding tolerance dose volume. A very pronounced shift of
the irradiation effect with respect to the isodoses is shown to illus-
trate the likely maximum inaccuracy of catheter positioning.
Mismatch areas in which we observed a dose response at doses
smaller than the tolerance dose of the total irradiation effect are
indexed with “MA+” and mismatch areas in which we did not
observe a dose response at doses higher than the tolerance dose of
the total irradiation effect are indexed with “MA- “.
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effect are indexed with ‘"MA+”. Conversely, mismatch
areas in which edema or hepatocyte dysfuntion did not
manifest at doses exceeding the tolerance dose of the
total irradiation effect are indexed with “MA-”,s e e
Figure 3. The ‘"MA+” and “MA-” mismatch areas by
definition have identical volumes.
A comprehensive description of the time course of
irradiation in brachytherapy is difficult since multiple
catheters with numerous dwell positions contribute to
dose fractionation in each voxel. First, the total voxel
dose, Dtot (x,y,z), depends on the voxel position. Second,
t h ed o s ec o n t r i b u t i o no fe a c hc a t h e t e r ,Di(x, y, z),
depends on the voxel position, (x,y,z), where i is the
catheter number. Third, each voxel is irradiated with a
different dose administration scheme, Dtot (x,y,z)=∑n
Di(x,y,z), where n is the number of catheters. The Bra-
chyVision software allows separation of the total dose
map, Dtot (x,y,z), into n separate dose maps, Di(x,y,z), for
each catheter i, see Figure 4. We calculated a total of
202 separate treatment plans using the treatment plan-
ning system to determine the contribution of each
catheter to the total of 48 irradiation effects. To esti-
mate the prolongation of irradiation by the
192Ir HDR
source we calculated a catheter contribution index, IP(x,
y,z), that uses the number of dose contribution pulses:
|IP(x,y,z)| = n −
n 
i=1

2 ·
Di(x,y,z)
Dtot(x,y,z)
− 1
2
(2)
The irradiation of a single voxel is prolonged as the
number of dose-contributing catheters increases. There-
fore, the catheter contribution index increases with the
number of contributing catheters. In case of a single con-
tributing catheter, IP = 0. In case of two equally contribut-
ing catheters, Di /Dtot =0 . 5 ,a n dIP =2 . 0 .IP is always in
the range between 0 and 2. The separate treatment plans
were combined in a voxelwise approach using an arith-
metic module implemented in Amira 3.1, see Figure 5.
Catheter contribution index IP(x,y,z) was then aver-
aged over the 3D maps of the mismatch areas, IP(MA+)
and IP(MA-). We calculated an asymmetry coefficient
with the following formula
ACI =
IP(MA+) − IP(MA−)
0.5(IP(MA+) + IP(MA−))
(3)
to compare the averaged catheter contribution indices
IP(MA+) and IP(MA-) calculated using Eq. 2. A value of
the asymmetry coefficient > 0 indicates that the catheter
contribution index in “MA+” is higher than in “MA-”,
vice versa a value of the asymmetry coefficient < 0



Figure 4 Dose separation. The 3D visualization shows a coronal
CT reconstruction with the calculated dose in Gy overlayed using
the patient in Fig. 1. The dose is applied using two catheters. The
two catheters were visualized in 3D using surface rendering of the
catheters labeled in the CT scan. A) Total dose, Dtot , overlayed.
B) Dose applied by the cranial catheter, D1. C) Dose applied by the
caudal catheter, D2 .
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is lower than in “MA-”.
Statistical analysis
The Generalized Estimating Equation (GEE) model was
employed to statistically assess limits of catheter posi-
tioning accuracy and the effects of prolonged irradiation
times on the tolerance dose of normal liver parenchyma.
For a dataset consisting of repeated measurements (2
MRI sequences, 2 follow-up dates) of a variable of inter-
est, a GEE model allows the correlation of outcomes
within one individual to be estimated and taken into
appropriate account in the equation which generates the
regression coefficients and their standard errors [15,16].
The GEE model was calculated with SAS, Version 9.1
(SAS Institute Inc., Cary, NC, USA). A p <0 . 0 5w a s
considered significant.
3 Results
The validation of image registration accuracy using
landmarks yielded a mean deviation of 2.64 mm (25%
quartile width (Q25 ): 0.28 mm, 75% quartile width
(Q75): 4.51 mm). Thus registration accuracy proved to
be sufficient for evaluating catheter positioning accuracy.
A total of 161 MRI examinations of 62 irradiation
effects were performed 6 and 12 weeks after HDR-BT.
Table 1 shows the mean volume and threshold dose of
hepatocyte dysfunction (T1-w images) and interstitial
edema (T2-w images) and corresponding liver tolerance
doses as well as the standard deviation between the
examinations at 6 and 12 weeks (6W and 12W).
A total of 96 follow-up MRI examinations of 30
patients with 38 irradiation effects were assessed to ana-
lyze methodical limitations of catheter positioning accu-
racy. Only patients with unidirectionally implanted, i.e.,
nearly parallel, catheters were included in the evaluation.
The median number of catheters inserted was 2 (Q25:1,
Q75: 3 catheters; range: 1-8 catheters).
Table 2 presents the axial, orthogonal, and total shifts
(in mm) between the center coordinates of the irradiation
effects and tolerance dose volumes in relation to the
direction vectors of catheter implantation. The mean
axial shift of hepatocyte dysfunction (T1-w images) was
-5. 3 ± 5.4 mm and of interstitial edema (T2-w images)
-5. 6 ± 6.0 mm in plane, indicating a shift of the irradia-
tion effect volume against the corresponding tolerance
dose volume in the direction of the catheter entry sites.
The orthogonal shift as a surrogate for registration inac-
curacy due to liver deformation was 4.0 ± 2.5 mm on
T1-w images and 4.6 ± 2.6 mm on T2-w images.
The orthogonal and axial shifts between the center
coordinates of the irradiation effect volume and the tol-
erance dose volume in relation to the direction vector of
catheter implantation were highly correlated in the T1-
w and T2-w MRI sequences (p = 0.003 and p <0 . 0 0 1 ,
respectively), as were the shifts between 6 and 12 weeks
examinations (p = 0.001 and p = 0. 004, respectively).
The asymmetry coefficient of the orthogonal and axial
shifts of the center coordinates of the irradiation effect
Figure 5 Catheter contribution index.T h ei m a g es h o w i n gt h e
separated isodoses of two catheters for the patient in Fig. 1 and
Fig. 4. The separated doses of the cranial and caudal catheter (Fig.
4) are used to calculate the catheter contribution index (Eq. 2)
shown in color coding. In case of two equally contributing
catheters, Di/Dtot = 0.5 and IP = 2.0. IP is always in the range
between 0 and 2.
Table 1 Normal liver tissue tolerance dose and volume of
irradiation effect
6w T1-w 12w T1-w 6w T2-w 12w T2-w
n = 44 36 48 33
Dose/Gy 13.7 ± 4.8 16.7 ± 5.0 14.3 ± 6.2 16.6 ± 6.4
Volume/
cm
3
190.3 ±
158.6
127.2 ±
118.8
190.0 ±
166.4
157.0 ±
143.5
Mean normal liver tissue tolerance dose and volume (± standard deviation)
for interstitial edema assessed by hyperintensity on T2-w images and
hepatocyte dysfunction assessed by hypointensity on T1-w images six/twelve
weeks (6w and 12w) after HDR-BT (n: number of MRI examinations evaluated).
Table 2 Shift between irradiation effect and planned
dose distribution
T1-w T2-w
n = 47 49
Axial shift/mm -5.3 ± 5.4 -5.6 ± 6.0
Orthogonal shift/mm 4.0 ± 2.5 4.6 ± 2.6
Total shift/mm 7.7 ± 4.4 8.4 ± 4.4
ACS 1.14 ± 0.43 1.04 ± 0.49
Mean axial, orthogonal, and total shift between center coordinates of the
irradiation effect and planned dose distribution in relation to the direction
vector of catheter implantation for T1-w and T2-w MRI data. Both follow-up
dates, 6w and 12w, were evaluated together. A negative value of the axial
shift indicates a shift into the direction of the catheter entry site. T1-w =
hepatocyte dysfunction, T2-w = interstitial edema, n = number of MR
examinations assessed.
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the direction vector of catheter implantation, ACS,w a s
1.14 ± 0.43 for hepatocyte dysfunction and 1.04 ± 0.49
for interstitial edema, indicating that the axial shift as a
surrogate for catheter dislocation within the catheter
track was predominant (p < 0.005). The asymmetry
coefficient was significantly affected by the MRI
sequence used (p = 0.014) but not by the change in the
irradiation effect volume between the 6-week and 12-
week examinations (p = 0.48).
A total of 129 follow-up MRI examinations of 44
patients with 48 irradiation effects were assessed to ana-
lyze the effect of prolonged irradiation time on the tol-
erance dose of normal liver parenchyma. All irradiation
effects were induced by at least 2 brachytherapy cathe-
ters. The median number of catheters per irradiation
effect was 4 (Q25:3 ;Q75: 6 catheters; range: 2-11 cathe-
ters). The average time for complete application of the
radiation dose was 1865 ± 758 seconds (range: 844 -
4432 seconds).
The volumes of the mismatch areas, “MA+” and “MA-
”, averaged over the 6-week and 12-week follow-up MRI
examinations and T1-w and T2-w acquisitions, was 40.6
±2 8 . 9c m
3 (23.5 ± 10.1%). The differences between the
mismatch area volumes with regard to 6-week and 12
week follow-up examinations and T1-w and T2-w MRI
are small, see Table 3. The average dose in “MA+” is
approximately 12Gy 6 weeks and 14Gy 12 weeks after
the intervention. The average dose in “MA-”,i s
approximately 22-23Gy 6 weeks and 28Gy 12 weeks
post intervention, see Table 3. The difference between
the average doses in the mismatch areas is significant (p
< 0.0001). The values for the catheter contribution
indices in the mismatch areas, IP(MA+) and IP(MA -), as
well as the asymmetry coefficients of the catheter contri-
bution indices in the mismatch areas, ACI , with respect
to hepatocyte dysfunction and interstitial edema and the
corresponding follow-up dates are displayed in Table 3.
The mean of ACI is > 0 in each subgroup, indicating
that the catheter contribution index in “MA+” is slightly
higher than in “MA-”. IP(MA+) and IP(MA-) are signifi-
cantly affected by the volume loss of the irradiation
effect between the 6-week and 12-week follow-up exam-
inations and consecutive shifts of the mismatch areas
towards the high dose regions of the dose plan (p =
0.0014). There is no significant difference between IP
(MA+) and IP(MA-) with respect to hepatocyte dysfunc-
tion and interstitial edema (p = 0.9).
4 Discussion
In this study, we sought to assess two methodical
aspects of HDR-BT: first, limits of catheter positioning
accuracy and, second, effects of prolonged irradiation on
the tolerance dose of normal liver parenchyma. The
mean shift between the center coordinates of the irra-
diation effect volume and corresponding tolerance dose
volume in relation to the direction vector of catheter
implantation is ≈ - 5 mm in plane, indicating a shift of
the irradiation effect in the direction of the catheter
entry site. The shift is within the slice thickness of 5
mm of the treatment planning CT but larger than could
be explained by registration inaccuracy, which is ≈ 3
mm, and inaccuracy due to local liver deformation in
the follow-up images, resulting in an overall registration
inaccuracy of ≈ 4-5 mm.
Determination of catheter positioning accuracy might
be limited by the delineation of the brachytherapy cathe-
ters in the treatment planning CT since applicator geo-
metry is entered manually. Partial volume effects in the
treatment planning datasets could be a potential source
of error in the treatment planning procedure, especially
for catheters in oblique direction, since correct place-
ment of the starting point of the catheter is dependent
on conspicuity of the catheter tip.
Another limitation is the dislocation of catheters
between acquisition of the planning CT and irradiation.
Although the angiographic sheaths containing the cathe-
ters were secured to the skin by suture, retraction of the
brachytherapy catheters within the catheter tracks might
potentially occur due to patient movement, e.g., when
the patient is transferred from the CT unit to the bra-
chytherapy unit, and liver movement during respiration.
However, the extent of the shift between an irradiation
Table 3 Mean dose, deviation of mean dose from normal
liver tissue tolerance dose, and dose protraction in
mismatch areas
6W T1-w 12W T1-w 6W T2-w 12W T2-w
n 3 52 74 02 7
D(MA+)/Gy 12.0 ± 4.3 14.1 ± 4.4 11.8 ± 5.4 14.0 ± 6.3
D(MA-)/Gy 23.2 ± 11.9 28.5 ± 11.0 22.2 ± 11.6 27.7 ± 15.1
ΔD(MA+)/Gy -2.1 ± 2.8 -3.2 ± 1.9 -2.1 ± 4.3 -3.0 ± 3.1
ΔD(MA-)/Gy 9.1 ± 7.5 11.2 ± 6.8 8.3 ± 6.6 10.7 ± 8.8
IP(MA+) 1.67 ± 0.33 1.69 ± 0.26 1.67 ± 0.31 1.70 ± 0.27
IP(MA-) 1.45 ± 0.39 1.35 ± 0.37 1.45 ± 0.37 1.39 ± 0.36
ACI 0.17 ± 0.28 0.25 ± 0.27 0.16 ± 0.26 0.23 ± 0.22
V (MA +/MA-)/cm
3 42.0 ± 26.7 38.2 ± 31.2 40.8 ± 29.2 43.0 ± 33.1
V (MA +/MA-)/% 21.8 ± 11.1 23.9 ± 7.8 23.1 ± 0.8 27.0 ± 9.0
D(MA+), D(MA-): Average dose in mismatch areas; “MA+” for response at doses
smaller than the tolerance dose and “MA-” for missing response at doses
exceeding the tolerance dose.
ΔD(MA+), ΔD(MA-): Difference between the average dose in “MA+"and “MA-”
and corresponding tolerance dose of the irradiation effect.
IP(MA+), IP(MA-): Catheter contribution index in “MA+” and “MA-”.
ACI : Asymmetry coefficient between the catheter contribution indices in “MA
+” and “MA-”.
V (MA +/MA-): Volume of the mismatch areas “MA+” and “MA-” in percent and
absolute value which is per definition identical for both areas.
Errors are given as standard deviation.
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does not suggest a significant dislocation of the bra-
chytherapy catheters within the catheter tracks.
The systematic shift between the irradiation effect
volume and planned dose distribution has to be consid-
ered in treatment planning when defining the CTV to
avoid underdosage of the tumor periphery. In our institu-
tion, the CTV comprises the tumor volume visible on
contrast-enhanced CT scans plus a 5-mm safety margin.
With regard to treatment planning, we conclude that a
slice thickness exceeding 3 mm potentially impairs cathe-
ter positioning accuracy. We furthermore propose that it
would be beneficial to increase the safety margin of the
CTV in the direction of the catheter tips from 5 to 10
mm to avoid underdosage and consecutive recurrence at
the tumor margin. The amount of mismatch (Table 3)
between planned dose distribution and irradiation effect
volume is determined by the registration accuracy or pos-
sibly by biological effects but does not allow to assess the
reproducibility of the CTV. Two studies evaluated the
accuracy of target positioning in extracranial stereotactic
radiotherapy (ESRT) using special patient fixation. For
mobile soft tissue targets, such as liver metastasis, Wulf
et al. [17] reported mean target deviations of 0.9 ± 4.5
mm, 0. 9 ± 3.0 mm, and 3.4 ± 3.2 mm in the craniocau-
dal, anteroposterior, and lateral directions, respectively,
when breathing control was applied. The mean 3D devia-
tion of the targets was 6.1 ± 4.6 mm.
For single-fraction therapy, Herfarth et al. [18]
reported mean target set-up deviations between treat-
ment planning and treatment of 4. 0 ± 2.5 mm, 2.2 ± 1.
8 mm, and 2.2 ± 1.7 mm in the craniocaudal, anteropos-
terior, and lateral directions, respectively. The mean 3D
deviation of the targets was 5.7 ± 2.5 mm.
The total in-plane deviation of the target location in
our study was slightly higher, 4-6 ± 2-6 mm. However,
we determined the effective positioning accuracy by
comparing the shift between the irradiation effect in fol-
low-up MRI and planned dose distribution. The authors
quoted above compared treatment planning images with
control CT datasets acquired before treatment [17,18]
and did not evaluate the treatment effect.
Based on metric analysis of target mobility and set-up
inaccuracy in the CT simulation prior to or during
treatment, safety margins for defining the planning tar-
get volume (PTV) of about 5 mm in axial and 5 - 10
mm in craniocaudal direction are commonly added to
the CTV in ESRT of lung and liver tumors [19]. In con-
trast to the present study, Wulf et al. evaluated the
reproducibility of the CTV of lung and liver tumors
within the planning target volume (PTV) over the entire
course of hypofractionated treatment in CT simulation
prior to application of each fraction [19]. The mean
volume ratio of the PTV to the CTV was 2.2 ± 0.6 in
liver targets. The authors showed that especially liver
tumors with a CTV exceeding 100 cm
3 were susceptible
to target deviation exceeding the standard safety mar-
gins for PTV definition. They suggested to increase the
PTV by adding a larger safety margin to ensure ade-
q u a t et a r g e td o s ed e p o s i t i o ni nt h e s eC T V s .I nb r a -
chytherapy, the applicator moves to a certain extent
together with the target and there is no need to increase
the safety margin for larger tumors.
Catheter dislocation in brachytherapy was mainly
investigated in fractionated HDR brachytherapy of the
prostate, which differs from the technique used here in
that a much larger number of catheters are implanted
for more than one day. Imaging techniques (cone beam
CT and CT) were used to assess catheter dislocation
between the first and second fraction, i.e., over 24
hours. Foster et al. found a mean catheter displacement
of 5. 1 mm, resulting in a significantly (p <0 . 0 1 )
decreased mean prostate V100 (volume receiving 100Gy
or more) from 93.8% to 76.2% [20]. Five patients had
maximum catheter displacement exceeding 10 mm.
Simnor et al. found a mean movement in caudal direc-
tion relative to the prostate base between the first and
second fraction of 7. 9 mm (range 0-21 mm). Planning
target volume dose D90% was reduced without move-
ment correction by a mean of 27.8% [21]. Kim et al.
found an average (range) magnitude of craniocaudal
catheter displacement of 2.7 mm (- 6.0 to 13.5 mm)
using bone markers and 5.4 mm (-3.75 to 18.0 mm)
using the center of two gold markers [22]. Catheter dis-
location in fractionated HDR brachytherapy of the pros-
tate is in the same range as in the present study but,
because of the much more complex irradiation geome-
try, the impact on dose coverage is much larger.
We assessed the effect of prolonged irradiation times
on the tolerance dose of normal liver tissue to determine
its relevance for treatment planning. A catheter contribu-
tion index served as a surrogate for prolonged pulsed
dose administration in nonoverlapping areas of the irra-
diation effect volume and the corresponding tolerance
dose volume. The catheter contribution index was
slightly but significantly higher in “MA+” than in “MA-”,
indicating a prolongation of dose application in “MA+”
compared to “MA-”. Based on published data, we would
have expected to find an increased tolerance dose of the
liver parenchyma in areas irradiated for a longer time, i.
e., by several catheters [6,7], even if the overall irradiation
time is less than one hour [8]. However, we found a
decreased tolerance dose of the liver parenchyma in areas
where the radiation dose was applied by several catheters
for a prolonged period of time.
We hypothesize that the effects of prolonged irradia-
tion on the tolerance dose of normal liver tissue might
have been obscured by other factors. For instance,
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may mimic irradiation effects, or scarring of the liver
tissue induced by catheter insertion may cause retrac-
tion of the irradiation effect towards the catheter entry
site. Furthermore, we propose that inaccuracies in the
positioning of the brachytherapy catheters are more pro-
nounced in areas where several catheters contribute to
the total irradiation dose and that the total applied
effective dose in “MA+” was higher than would have
been expected from the treatment plan. Since steep
dose gradients are an inherent quality of interstitial
HDR-BT, the shift of active dwell positions of one or
several catheters towards the tumor periphery would be
sufficient to significantly increase the applied dose out-
side the CTV. As the number of catheters increases, the
probability of a dose shift due to slight inaccuracy in
catheter positioning likely increases as well.
We conclude that the effects of prolonged irradiation
time are of minor importance for interstitial HDR-BT
compared to other factors such as positioning accuracy
of brachytherapy catheters and do not have to be taken
into account in treatment planning in HDR-BT if the
total irradiation time does not significantly exceed one
hour.
The study has several limitations. Obviously one key
issue of the study is the registration accuracy. The vali-
dation of registration accuracy was based on corre-
sponding vessel bifurcations identified in the planning
CT and follow-up MR images by an experienced radiol-
ogist [23,24]. We applied affine registration, allowing 12
degrees of freedom, which compensates for whole organ
deformation and yielded an accuracy of ≈ 3m mw i t h
respect to vessel bifurcations within the central parts of
the liver, comparable to other studies [25,26]. Affine
registration has been proven to be precise and robust
for liver registration [25-27]. However, local liver defor-
mation resulting from compression by adjacent organs
(such as the stomach), different respiration levels, or the
implanted catheters in the treatment planning CT data
might not be sufficiently compensated for. To ade-
quately compensate for these effects a finite element
model-based deformable image registration would have
been superior [23,24]. We tried to compensate for the
limitations of affine registration by restricting the regis-
tration to the liver [25]. Using this procedure, we
achieved a registration accuracy with a mean deviation
of 2.64 mm, which was smaller than that of the nonrigid
registration used by Elhawary et al. [28], for which the
authors reported a mean target registration error of. 4.1
mm and a mean 95
th-percentile Hausdorff distance of 3.
3 mm.
Second, the catheter contribution index has to be con-
sidered a rough simplification, merely providing a first
estimate of the effect of prolonged dose administration.
Dose administration was considered highly prolonged if
the index was 2 (meaning that each catheter of the bra-
chytherapy implant contributed < 50% of the irradiation
dose in the mismatch area). It was considered fairly pro-
longed if the value was between 1 and 2 (indicating that
more than 25% of the total irradiation dose in the mis-
m a t c ha r e aw a sa p p l i e db ym o r et h a n1c a t h e t e r ) ,a n d
nonprolonged if the value was ≤ 1 (meaning that 75% or
more of the total irradiation dose in the mismatch area
was applied by 1 catheter only). Nevertheless, the tool is
sufficient to rule out practically relevant effects of pro-
longed dose administration in HDR-BT in vivo.
5 Conclusions
In conclusion, positioning accuracy of brachytherapy
catheters is sufficiently precise with approx. 5-6 mm.
Accuracy was within the 5-mm slice thickness of the
treatment planning CT. Thus positioning accuracy is
potentially affected by inaccuracy in the delineation of
the brachytherapy catheters during treatment planning
due to partial volume effects in the planning CT.
Retraction of the catheters within the catheter tracks
during transfer of the patient from the CT unit to the
brachytherapy unit might occur; however, this retraction
is not pronounced. Therefore, CT-guided HDR-BT can
be safely performed, even if CT and brachytherapy are
not performed in the same unit. Effects of prolonged
irradiation times on the tolerance dose of normal liver
tissue are negligible compared to positioning accuracy
of brachytherapy catheters and do not have to be taken
into account in treatment planning if the total irradia-
tion time does not significantly exceed one hour.
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